Machine learning to predict early gastric cancer
Part of Cancer, Digestive system clinical trials.
This study uses machine learning to find patterns in patient data that might help predict early-stage stomach cancer. It could help doctors catch the disease sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a stomach tissue sample tested (biopsy).
- Your pathology results are clear and complete.
- Your lab test results are mostly available.
- You do not have advanced or spreading stomach cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an artificial intelligence tool that analyzes images taken during stomach endoscopy to help diagnose early-stage stomach cancer or precancerous changes. The goal is to improve how doctors identify and treat these lesions early, when treatment is most effective.
This study uses genetic sequencing to learn more about early stomach cancer and precancerous stomach polyps. It may help improve how these conditions are understood and potentially guide future care, using genetic information from stored tissue samples.
This study looks at people with early-stage stomach cancer to learn more about how different treatments work. It uses information from patients who were treated at a specific hospital, which may help doctors better understand the best ways to treat this condition.
This study tests if artificial intelligence can predict whether early-stage stomach cancer has spread to lymph nodes. It also evaluates how well doctors assess the cancer. If the technology works, it could help guide treatment decisions.
This study uses information from CT scans done before stomach cancer surgery to see if it can predict whether the cancer may come back early. Researchers want to find patterns in the scans that might help doctors plan better follow-up care.
This study uses your existing CT/MRI images and biopsy tissue to build a computer model that may help predict if your stomach cancer will spread to the abdomen or cause weight loss. You won't receive a new treatment, but your data could improve future care for stomach cancer patients.
Hear when a new Early Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.